To that end, we analyzed 61 tagging SNPs in ABCB1, ABCG2, PXR, and CAR genes and studied their effects regarding different parameters of response depth and duration as well as toxicity in CML patients. This evidence concerns the gene NR1I2 and chronic myelogenous leukemia, BCR-ABL1 positive.